Role of respiratory and cardiovascular disease as a motivational factor for smoking cessation

O. C. Deleanu, T. Alexandru, R. Ulmeanu, O. M. Udrea, I. Mierlus-Mazilu, S. Mihaicuta, F. D. Mihaltan (Bucharest, Timisoara, Romania)

Source: Annual Congress 2011 - Epidemiology of smoking and smoking cessation interventions
Session: Epidemiology of smoking and smoking cessation interventions
Session type: Thematic Poster Session
Number: 4243
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. C. Deleanu, T. Alexandru, R. Ulmeanu, O. M. Udrea, I. Mierlus-Mazilu, S. Mihaicuta, F. D. Mihaltan (Bucharest, Timisoara, Romania). Role of respiratory and cardiovascular disease as a motivational factor for smoking cessation. Eur Respir J 2011; 38: Suppl. 55, 4243

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Influence of respiratory and cardiovascular diseases on smoking cessation.
Source: International Congress 2017 – Smoking and health hazards
Year: 2017


Effects of childhood smoking on respiratory symptoms
Source: Annual Congress 2005 - What's new in tobacco and lung disease
Year: 2005


Impact of the diagnosis of a respiratory disease in smoking cessation
Source: International Congress 2019 – Tobacco cessation interventions in different settings and populations
Year: 2019

Quitting smoking and reduction of cardiovascular risk factors
Source: International Congress 2016 – Smoking-related diseases
Year: 2016


Smoking cessation in patients with respiratory diseases
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005


Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases?
Source: Eur Respir J 2009; 33: 468-480
Year: 2009



Smoking cessation: key for both COPD and cardiovascular disease, but how to manage it?
Source: International Congress 2017 – COPD and comorbid cardiovascular diseases
Year: 2017


Is cardiovascular co-morbidity increasing success rate of smoking cessation at respiratory disorders inpatients?
Source: Annual Congress 2007 - Smoking cessation
Year: 2007


Efficacy of confronting smokers with airflow limitation for smoking cessation
Source: Eur Respir J 2009; 33: 754-762
Year: 2009



Analysis of influence of only one cigarette in smokers concerning some biological risk factors for cardiovascular disease
Source: Eur Respir J 2006; 28: Suppl. 50, 247s
Year: 2006

Exposure to second-hand smoking during childhood and/or adulthood as a risk factor for respiratory disease
Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Year: 2020


Smoking cessation and prevention
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=242
Year: 2006

Smoking and passive smoking as risk factors for development of lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 597s
Year: 2005

Success predicting factors in smoking cessation in asthma patients.
Source: International Congress 2019 – Tobacco cessation interventions in different settings and populations
Year: 2019


Smoking cessation of respiratory patients
Source: International Congress 2017 – Smoking cessation
Year: 2017


Smoking cessation by hospitalization yields a high rate of smoke abstinence in COPD-patients
Source: Annual Congress 2007 - Smoking and COPD
Year: 2007




Smoking cessation strategies in patients with COPD
Source: Eur Respir J 2013; 41: 727-734
Year: 2013